Latest News
September 17, 2019
By 2050, nearly 150 million are expected to be living with dementia. At present 58% of people with dementia live in low and middle-income countries (LMICs), but by 2050 [...]
September 16, 2019
In March 2019, pharmaceutical company Biogen announced the halt of its global phase-three trials testing the effectiveness of aducanumab in treating [...]
